pharma news india

News


22 April, 2017

Vitas presents at ECCMID 2017

Vitas Pharma presented its work on novel diagnostic tests at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in Vienna, Austria. The abstract was titled, "Rapid molecular tests to detect carbapenem resistance from direct clinical samples".

24 March, 2017

Vitas Pharma joins the AMR core team

Vitas Pharma is invited by the World Economic Forum and the Wellcome Trust to join the AMR Core Team of public and private sector stakeholders to lead efforts to tackle antimicrobial resistance by operationalizing incentive models for the development of new antimicrobial drugs.

22 January, 2017

Vitas Pharma's work on drugs to overcome resistance to last line antibiotics

Drug discovery companies have formidable scientific and business challenges...

Read More

22 November, 2016

Winners of the Discovery Awards

Vitas Pharma wins a Discovery Award from the Longitude Prize committee to develop its diagnostic product for the rapid detection of bacterial infections..

Read More

4 August, 2016

Economic Times Startup Awards 2016

Radha Rangarajan nominated to the Economic Times Start-up awards

Read More

12 April, 2016

New antibiotics to overcome antibacterial resistance presented at ECCMID

Antimicrobial drug pipelines have been presented at the annual congress (ECCMID) of the European Society…

Read More

20 January, 2016

Vitas Pharma is a signatory to the Declaration by the Pharmaceutical...

Vitas Pharma is a signatory to the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industry on Combating Antimicrobial Resistance at the World Economic Forum, Davos, Switzerland.

Read More

12 January, 2016

Why India needs to make antibiotic drug-resistance a priority

In 2010, a study published in The Lancet Infectious Diseases drew the world's attention to the emergence of a superbug from India, a bacterium resistant to almost all antibiotics.

Read More

30 August, 2015

India's Drug Warriors

It is turning out to be a serious health scare. With bacteria fast developing resistance to existing antibiotics, we may soon reach a stage where a simple bruise may prove fatal.

Read More

24 August, 2015

Radha Rangarajan is featured in Outlook magazine in a story on women led start-ups in India

Radha Rangarajan got to thinking about an idea to fight malaria from her research on knocking out a gene...

Read More

5 March, 2015

Review on Antimicrobial Resistance

Vitas Pharma participates in discussions organized by the Public Health Foundation of India (PHFI) and the Review on Antimicrobial Resistance (AMR)

18 Jan, 2015

Why Indian startups like Bugworks, Vitas Pharma have entered the field of drug discovery

Talk to anyone associated with public health, and they will tell you about the miasma of antibiotic resistance sweeping the world.

Read More

19 Oct, 2014

Women Entrepreneurs, Hyderabad

Radha Rangarajan addresses the Confederation of Women Entrepreneurs, Hyderabad

Read More

07 Sep, 2014

Interscience Conference

The Company presented a poster at the Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC.

Read More

14 Jul, 2014

National Institute of Animal Biotechnology, Hyderabad

The Company participates in a panel discussion on Antimicrobial resista...

Read More

04 Apr, 2014

Indian private investors extremely risk averse

In the field of new drug discovery for antibiotics, there are only a handful of companies worldwide.

Read More

23 Nov, 2013

Annual Meeting of the Indian Association

Radha Rangarajan gives a talk at the Annual Meeting of the Indian Association of Medical Microbiologists

Read More

21 May, 2013

Best Woman Entrepreneur

Radha Rangarajan receives the TV5 business leader award for the best woman entrepreneur led start-up, Hyderabad

Read More

20 Mar, 2013

Asian Biotech showcase at the BioPharma Asia

The Company is featured in the Asian Biotech showcase at the BioPharma Asia, Singapore

Read More

19 Feb, 2013

Vitas Pharma focuses on tackling MRSA infections

Methicillin-resistant Staphylococcus aureus (MRSA), a type of staphylococcus bacteria that is resistant to many antibiotics, accounts for 30-50 percent of isolates in hospitals in India and worldwide.

Read More

23 Feb, 2011

Innovation and entrepreneurship in emerging biotechnology

Radha Rangarajan presents the Vitas Pharma strategy at BioAsia...

Read More

22 April, 2017

Vitas presents at ECCMID 2017

Vitas Pharma presented its work on novel diagnostic tests at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in Vienna, Austria. The abstract was titled, "Rapid molecular tests to detect carbapenem resistance from direct clinical samples".

24 March, 2017

Vitas Pharma joins the AMR core team

Vitas Pharma is invited by the World Economic Forum and the Wellcome Trust to join the AMR Core Team of public and private sector stakeholders to lead efforts to tackle antimicrobial resistance by operationalizing incentive models for the development of new antimicrobial drugs.

22 January, 2017

Vitas Pharma's work on drugs to overcome resistance to last line antibiotics

Drug discovery companies have formidable scientific and business challenges...

Read More

22 November, 2016

Winners of the Discovery Awards

Vitas Pharma wins a Discovery Award from the Longitude Prize committee to develop its diagnostic product for the rapid detection of bacterial infections.

Read More

4 August, 2016

Economic Times Startup Awards 2016

Radha Rangarajan nominated to the Economic Times Start-up awards

Read More

12 April, 2016

New antibiotics to overcome antibacterial resistance presented at ECCMID

Antimicrobial drug pipelines have been presented at the annual congress (ECCMID) of the European Society…

Read More

20 January, 2016

Vitas Pharma is a signatory to the Declaration by the Pharmaceutical...

Vitas Pharma is a signatory to the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industry on Combating Antimicrobial Resistance at the World Economic Forum, Davos, Switzerland.

Read More

12 January, 2016

Why India needs to make antibiotic drug-resistance a priority

In 2010, a study published in The Lancet Infectious Diseases drew the world's attention to the emergence of a superbug from India, a bacterium resistant to almost all antibiotics.

Read More

30 August, 2015

India's Drug Warriors

It is turning out to be a serious health scare. With bacteria fast developing resistance to existing antibiotics, we may soon reach a stage where a simple bruise may prove fatal.

Read More

24 August, 2015

Radha Rangarajan is featured in Outlook magazine in a story on women led start-ups in India

Radha Rangarajan got to thinking about an idea to fight malaria from her research on knocking out a gene...

Read More

5 March, 2015

Review on Antimicrobial Resistance

Vitas Pharma participates in discussions organized by the Public Health Foundation of India (PHFI) and the Review on Antimicrobial Resistance (AMR)

18 Jan, 2015

Why Indian startups like Bugworks, Vitas Pharma have entered the field of drug discovery

Talk to anyone associated with public health, and they will tell you about the miasma of antibiotic resistance sweeping the world.

Read More

19 Oct, 2014

Women Entrepreneurs, Hyderabad

Radha Rangarajan addresses the Confederation of Women Entrepreneurs, Hyderabad

Read More

07 Sep, 2014

Interscience Conference

The Company presented a poster at the Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC.

Read More

14 Jul, 2014

National Institute of Animal Biotechnology, Hyderabad

The Company participates in a panel discussion on Antimicrobial resista...

Read More

04 Apr, 2014

Indian private investors extremely risk averse

In the field of new drug discovery for antibiotics, there are only a handful of companies worldwide.

Read More

23 Nov, 2013

Annual Meeting of the Indian Association

Radha Rangarajan gives a talk at the Annual Meeting of the Indian Association of Medical Microbiologists

Read More

21 May, 2013

Best Woman Entrepreneur

Radha Rangarajan receives the TV5 business leader award for the best woman entrepreneur led start-up, Hyderabad

Read More

20 Mar, 2013

Asian Biotech showcase at the BioPharma Asia

The Company is featured in the Asian Biotech showcase at the BioPharma Asia, Singapore

Read More

19 Feb, 2013

Vitas Pharma focuses on tackling MRSA infections

Methicillin-resistant Staphylococcus aureus (MRSA), a type of staphylococcus bacteria that is resistant to many antibiotics, accounts for 30-50 percent of isolates in hospitals in India and worldwide.

Read More

23 Feb, 2011

Innovation and entrepreneurship in emerging biotechnology

Radha Rangarajan presents the Vitas Pharma strategy at BioAsia...

Read More